Healthcare entity

CDC

organization

Against the same-window beat baseline of 25% negative, this entity's 40% share is more negative. Coverage clusters in regulation, which accounts for 7 of those 10, with the remainder spread across 2 other categories. Of the tracked stories, 4 of 10 also mention FDA, the most common co-covered peer.

Last mentioned: Mar 25, 2026

Entity pulse

Recent coverage · CDC

10 stories
6.1 avg impact
10% positive
40% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 30 percentage points.

  • 10% positive
  • 50% neutral
  • 40% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about CDC

Against the same-window beat baseline of 25% negative, this entity's 40% share is more negative. Coverage clusters in regulation, which accounts for 7 of those 10, with the remainder spread across 2 other categories. Of the tracked stories, 4 of 10 also mention FDA, the most common co-covered peer. The 150-day window averages about 0.5 stories each week. The busiest single day carried 2. At 6.1, the average consequence score sits above the same-window beat average of 6. Source depth averages 3.3 original sources per story, versus 4 across the same-window beat baseline. We currently track 10 Healthcare stories that mention CDC, published between February 20, 2026 and July 19, 2026.

Stories tracked
10
Per week
0.5
Negative
40%
Sources per story
3.3

Computed from the 10 stories linked to this entity, with beat comparisons drawn from all 865 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering CDC. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Contact Tracing Expansion

    Epidemiologists begin interviewing patients to map potential community exposure sites.

  2. Initial Diagnosis

    Two Missouri residents are confirmed positive for mpox by state laboratories.

  3. Public Health Alert

    Missouri DHSS issues a formal notice to clinicians to increase screening and reporting.

  4. Dual Leadership Confirmed

    Official confirmation that Bhattacharya will lead both agencies to streamline federal health response.

  5. Acting Appointment

    Reports emerge that NIH Director Jay Bhattacharya will take over as acting head of the CDC.

Stories mentioning CDC 10

Health Policy Strongly negative

FDA Recall: 3 Infants Hospitalized with Botulism After Organic Formula

Three infants in three states were diagnosed with botulism after consuming Nara Organics powdered formula, prompting a voluntary recall of all whole milk formula. All babies recovered, but the FDA and CDC investigation highlights risks of powdered formula for newborns and emphasizes clinical vigilance among pediatricians.

2 sources
Health IT Positive

Large Study Confirms Maternal COVID-19 Vaccination Protects Infants Post-Birth

A comprehensive multi-site study has confirmed that COVID-19 vaccination during pregnancy significantly reduces the risk of hospitalization for infants in their first six months of life. The findings provide robust evidence for the benefits of transplacental antibody transfer in protecting neonates who are not yet eligible for vaccination.

14 sources

Source: publicradiotulsa.org · wcsufm.org

Market Trends Strongly negative

US Childhood Obesity Hits Record High, Triggering Public Health Crisis

New data reveals that United States childhood obesity rates have reached an all-time high, surpassing previous peaks and signaling a deepening public health crisis. The surge is prompting urgent calls for policy intervention, increased access to pediatric weight management technologies, and a reevaluation of nutritional standards.

3 sources

Source: channel933.iheart.com · mymagic989.iheart.com

Health Policy Neutral

Scientific Studies Rebut RFK Jr. Claims on Vaccines and Pharmaceuticals

A series of recent clinical studies have directly challenged the public health assertions made by Robert F. Kennedy Jr. regarding vaccines, Tylenol, and antidepressants. These findings underscore a growing tension between evidence-based medicine and the policy platform of the potential future leadership at the Department of Health and Human Services.

2 sources

Source: nbclosangeles.com · nbcsandiego.com

CDC is linked from 10 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.